WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
By Robin Foster HealthDay Reporter
FRIDAY, JUNE 21, 2024 -- Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.
The WHO warning said that the international health agency has fielded several reports of fake semaglutide -- the active ingredient in Novo Nordisk’s Wegovy and Ozempic -- in all geographic regions of the world since 2022.
“WHO advises healthcare professionals, regulatory authorities and the public be aware of these falsified batches of medicines,” Dr. Yukiko Nakatani, WHO Assistant Director-General for Access to Medicines and Health Products, said in the warning. “We call on stakeholders to stop any usage of suspicious medicines and report to relevant authorities.”
Meanwhile, Lilly said in an open letter that it was “deeply concerned” about phony or compounded versions of tirzepatide, the active ingredient in the Lilly weight-loss drugs Mounjaro and Zepbound.
"These [fake] products are often advertised and sold online, through social media or at certain med-spas," Lilly said in its letter. "They may contain no medicine, the wrong medicine, incorrect dosages or multiple medicines mixed together, which could result in serious harm. They are never safe to use."
Novo Nordisk has issued similar warnings in the past about its medications.
The WHO said patients can protect themselves by using prescriptions from licensed physicians to buy the medications. Consumers should also avoid buying the drugs from unfamiliar sources, the agency added.
For its part, Lilly noted any products marketed as tirzepatide and not Mounjaro or Zepbound were not made by the drugmaker and are not approved for use by the U.S. Food and Drug Administration.
Sources
- Eli Lilly, news release, June 2024
- World Health Organization, news release, June 20, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger
FRIDAY, Aug. 2, 2024 -- Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the...
Sit a Lot? Exercise Might Offset the Damage to Your Health
FRIDAY, Aug. 2, 2024 -- People can offset hours spent sitting around with minutes of active exercise each week, a new study claims. Folks who are sedentary for eight or more...
FDA Warns of Accidental Overdoses from Compounded Versions of Ozempic
TUESDAY, July 30, 2024 -- People taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns. These ODs typically are due...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.